/

ImmunoGen, Inc.

IMGN US

IMGN USImmunoGen, Inc.

United States Composite

31.23

USD

-0.01

(-0.03%)

-0.28EPS Dil.

-111.51P/E

8.30BMarket Cap

ImmunoGen, Inc.

IMGN

(United States Composite)

Recent

price

31.23

P/E

ratio

-111.51

div

yld

- -

ROIC.AI

Legends:

Stock price

0.29

Beta (1.0 Market)

% total return 04/18

Stock

S&P500

YTD

648.92

- -

315.29

- -

1,169.51

- -

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

FRC

0.92

0.94

0.55

0.24

0.28

0.21

0.42

0.70

0.99

0.69

1.18

0.38

0.55

0.75

0.34

0.43

1.10

-0.45

-0.75

-0.63

-0.87

-0.85

-0.95

-0.87

-0.83

-0.71

-1.67

-0.98

-1.21

-0.70

-0.25

-0.68

-0.88

-0.28

-0.43

-0.89

-0.30

-0.72

-0.15

-0.48

-0.76

-0.72

-0.73

-1.55

0.07

-1.23

-0.62

-0.45

-0.83

-0.91

-0.76

- -

-6.06

-5.69

-5.63

-5.47

-5.64

-6.47

-6.80

-7.53

-8.18

-9.78

-7.75

-7.91

-8.57

-6.82

-6.67

-7.48

-6.42

1.38

1.09

1.17

1.50

1.83

1.08

1.44

0.88

0.41

-0.94

-0.14

0.07

-0.51

0.46

1.48

0.69

2.11

140

148

176

206

254

263

115

132

109

288

-58.16

-84.75

-113.68

-367.46

-311.77

-447.86

-205.46

-119.43

-63.66

-208.31

-50.42

-295.17

-85.98

-15.79

-179.04

-203.06

-27.88

-19

-32

-51

-58

-73

-71

-61

-145

-96

-169

-104

-44

-139

-223

-74

- -

-49.69

-79.55

-114.11

-365.14

-301.86

-448.24

-204.90

-119.15

-71.01

-241.35

-83.17

-315.91

-126.57

-33.54

-199.41

-204.93

-25.56

103

187

150

182

130

256

193

221

208

131

202

399

182

632

- -

102

140

122

-82

-18

-76

326

156

562

- -

Capital Structure

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

ST Debt

LT Borrowings

- -

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

226

249

266

Market Capitalization

868

4,693

4,219

Working Capital

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

Total Current Assets

244

669

767

Cash, Cash Equivalents & STI

201

572

606

Accounts Receivable, Net

131

Inventories

Total Current Liabilities

102

135

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

36.70%

14.10%

55.71%

Net Income, GAAP

-34.33%

-51.25%

-60.43%

Free Cash Flow

-293.77%

-529.36%

-35.09%

Total Cash Common Dividend

- -

Total Equity

-126.30%

-192.07%

-52.15%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

2022

109

2023

113

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.17

-0.15

-0.18

-0.17

-0.68

2022

-0.10

-0.24

-0.31

-0.23

-0.88

2023

-0.16

-0.02

0.11

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Business: ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian cancer; and a cell-surface protein expressed in various epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers, as well as Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti-FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts. As of February 12, 2024, ImmunoGen, Inc. operates as a subsidiary of AbbVie Inc.

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

TTM

FRC

0.92

0.94

0.55

0.24

0.28

0.21

0.42

0.70

0.99

0.69

1.18

0.38

0.55

0.75

0.34

0.43

1.10

-0.45

-0.75

-0.63

-0.87

-0.85

-0.95

-0.87

-0.83

-0.71

-1.67

-0.98

-1.21

-0.70

-0.25

-0.68

-0.88

-0.28

-0.43

-0.89

-0.30

-0.72

-0.15

-0.48

-0.76

-0.72

-0.73

-1.55

0.07

-1.23

-0.62

-0.45

-0.83

-0.91

-0.76

- -

-6.06

-5.69

-5.63

-5.47

-5.64

-6.47

-6.80

-7.53

-8.18

-9.78

-7.75

-7.91

-8.57

-6.82

-6.67

-7.48

-6.42

1.38

1.09

1.17

1.50

1.83

1.08

1.44

0.88

0.41

-0.94

-0.14

0.07

-0.51

0.46

1.48

0.69

2.11

140

148

176

206

254

263

115

132

109

288

-58.16

-84.75

-113.68

-367.46

-311.77

-447.86

-205.46

-119.43

-63.66

-208.31

-50.42

-295.17

-85.98

-15.79

-179.04

-203.06

-27.88

-19

-32

-51

-58

-73

-71

-61

-145

-96

-169

-104

-44

-139

-223

-74

- -

-49.69

-79.55

-114.11

-365.14

-301.86

-448.24

-204.90

-119.15

-71.01

-241.35

-83.17

-315.91

-126.57

-33.54

-199.41

-204.93

-25.56

103

187

150

182

130

256

193

221

208

131

202

399

182

632

- -

102

140

122

-82

-18

-76

326

156

562

- -